All companies
Visit website
ACHIEVE CLINICS, INC.
OperatingAchieve Clinics, Inc.
Healthcare · Technology · Founded 2021
Free-to-patient immune cell banking to supercharge cancer cell therapy access and innovation
Valuation cap ⓘ
$5.0M
As of Dec 2023 · from ACHIEVE CLINICS, INC. Convertible Note 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$53,518
Across 1 round since 2023
Financials
FY2021–FY2023 · from SEC filings · hover any figure for its source$0
2021
$0
−$19K
2022
$3K
−$75K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$3,071
Cost of goods sold
$0
$0
$1,591
Gross margin
—
—
48%
Net income
$0
-$19,147
-$75,072
Taxes paid
$0
$512
$1,250
Balance sheet
Cash
$0
$3,290
$74,672
Accounts receivable
$0
$0
$2,880
Total assets
$0
$3,290
$78,176
Short-term debt
$0
$0
$4,509
Long-term debt
$0
$14,231
$94,629
Total liabilities
$0
$14,231
$99,138
Other
Headcount
—
2
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$5.0M
Valuation cap
ACHIEVE CLINICS, INC. Convertible Note 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $53.5K / $120KInvestors 7Valuation cap $5M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 3 annual reports (FY2023–FY2025)
7 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001990607
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.